Targeted therapies for certain types of cancer and rare disease offer new hope for these patient populations. But how can we ensure that these treatments are also developed with minority communities in mind?
Karmanos Cancer Institute
The INVEST Precision Medicine conference cast a spotlight on the role of children’s hospitals, biopharma companies, diagnostic companies and startups in biopharma innovation. The video recordings of the conference sessions are now available to view.
Minority groups get left out of clinical trials and studies for many reasons, including lack of access, awareness and trust in the healthcare system. But, according to panelists at MedCity INVEST Precision Medicine, researchers along with patient advocates can help tackle these hurdles by working together and being intentional in their approach.
Register for the INVEST Precision Medicine conference, which kicks off today. Over the next three days industry experts will talk about precision medicine developments across pediatrics, bioinformatics, startups and more.